Companies House 14740780 2025-02-28 2025-02-28 2024-02-29 false iso4217:GBP xbrli:pure 14740780 2023-03-20 2024-02-28 14740780 2025-02-28 14740780 2024-02-29 2025-02-28 14740780 2024-02-28 14740780 curr:PoundSterling 2024-02-29 2025-02-28 14740780 uk-bus:CompanyLimitedByGuarantee 2024-02-29 2025-02-28 14740780 uk-bus:FRS102 2024-02-29 2025-02-28 14740780 uk-bus:AuditExempt-NoAccountantsReport 2024-02-29 2025-02-28 14740780 uk-bus:FullAccounts 2024-02-29 2025-02-28 14740780 uk-bus:RegisteredOffice 2024-02-29 2025-02-28 14740780 uk-bus:Director1 2024-02-29 2025-02-28 14740780 uk-bus:Director2 2024-02-29 2025-02-28 14740780 uk-bus:Director3 2024-02-29 2025-02-28 14740780 uk-bus:Director4 2024-02-29 2025-02-28 14740780 uk-bus:Director5 2024-02-29 2025-02-28 14740780 uk-bus:Director6 2024-02-29 2025-02-28 14740780 uk-bus:Director7 2024-02-29 2025-02-28 14740780 uk-bus:Director8 2024-02-29 2025-02-28 14740780 uk-bus:Director9 2024-02-29 2025-02-28 14740780 uk-bus:Director10 2024-02-29 2025-02-28 14740780 uk-bus:Director11 2024-02-29 2025-02-28 14740780 uk-bus:Director12 2024-02-29 2025-02-28 14740780 uk-bus:Director13 2024-02-29 2025-02-28 14740780 uk-bus:Director14 2024-02-29 2025-02-28 14740780 uk-bus:Director15 2024-02-29 2025-02-28 14740780 uk-bus:Director16 2024-02-29 2025-02-28 14740780 uk-bus:Director17 2024-02-29 2025-02-28 14740780 uk-bus:Director18 2024-02-29 2025-02-28 14740780 uk-bus:Director19 2024-02-29 2025-02-28 14740780 uk-bus:Director20 2024-02-29 2025-02-28 14740780 uk-bus:Director21 2024-02-29 2025-02-28 14740780 uk-bus:CompanySecretary1 2024-02-29 2025-02-28 14740780 core:AfterOneYear 2025-02-28 14740780 core:AfterOneYear 2024-02-28 14740780 core:WithinOneYear 2025-02-28 14740780 core:WithinOneYear 2024-02-28 14740780 core:WithinOneYear 2024-02-29 2025-02-28 14740780 core:AfterOneYear 2025-02-28 14740780 core:AfterOneYear 2024-02-28 14740780 core:AfterOneYear 2024-02-29 2025-02-28 14740780 core:ShareCapital 2025-02-28 14740780 core:ShareCapital 2024-02-28 14740780 core:SharePremium 2025-02-28 14740780 core:SharePremium 2024-02-28 14740780 core:OtherReservesSubtotal 2025-02-28 14740780 core:OtherReservesSubtotal 2024-02-28 14740780 core:RevaluationReserve 2025-02-28 14740780 core:RevaluationReserve 2024-02-28 14740780 core:RetainedEarningsAccumulatedLosses 2025-02-28 14740780 core:RetainedEarningsAccumulatedLosses 2024-02-28 14740780 1 2024-02-29 2025-02-28 14740780 2 2024-02-29 2025-02-28 14740780 3 2024-02-29 2025-02-28 14740780 core:LandBuildings 2024-02-29 2025-02-28 14740780 core:LandBuildings 2025-02-28 14740780 core:LandBuildings 2023-03-20 2024-02-28 14740780 core:LandBuildings 2024-02-28 14740780 core:PlantMachinery 2024-02-29 2025-02-28 14740780 core:PlantMachinery 2025-02-28 14740780 core:PlantMachinery 2023-03-20 2024-02-28 14740780 core:PlantMachinery 2024-02-28 14740780 core:FurnitureFittingsToolsEquipment 2024-02-29 2025-02-28 14740780 core:FurnitureFittingsToolsEquipment 2025-02-28 14740780 core:FurnitureFittingsToolsEquipment 2023-03-20 2024-02-28 14740780 core:FurnitureFittingsToolsEquipment 2024-02-28 14740780 core:OfficeEquipment 2024-02-29 2025-02-28 14740780 core:OfficeEquipment 2025-02-28 14740780 core:OfficeEquipment 2023-03-20 2024-02-28 14740780 core:OfficeEquipment 2024-02-28 14740780 core:Vehicles 2024-02-29 2025-02-28 14740780 core:Vehicles 2025-02-28 14740780 core:Vehicles 2023-03-20 2024-02-28 14740780 core:Vehicles 2024-02-28 14740780 core:NetGoodwill 2024-02-29 2025-02-28 14740780 core:NetGoodwill 2025-02-28 14740780 core:NetGoodwill 2023-03-20 2024-02-28 14740780 core:NetGoodwill 2024-02-28 14740780 core:IntangibleAssetsOtherThanGoodwill 2024-02-29 2025-02-28 14740780 core:IntangibleAssetsOtherThanGoodwill 2025-02-28 14740780 core:IntangibleAssetsOtherThanGoodwill 2023-03-20 2024-02-28 14740780 core:IntangibleAssetsOtherThanGoodwill 2024-02-28

# AREMATHERAPY C.I.C.

## Company limited by guarantee

## Company Registration Number:
14740780 (England and Wales)

## Unaudited statutory accounts for the year ended 28 February 2025

## Period of accounts

## Start date: 29 February 2024

## End date: 28 February 2025

# AREMATHERAPY C.I.C.

## Contents of the Financial Statements

for the Period Ended 28 February 2025

Directors report |
Profit and loss |
Balance sheet |
Additional notes |
Balance sheet notes |
Community Interest Report |

# AREMATHERAPY C.I.C.

Directors' report period ended 28 February 2025

The directors present their report with the financial statements of the company for the period ended 28 February 2025

Principal activities of the company

The principal activity of the company throughout the year was health care, education, cultural and other social services

Directors

The directors shown below have held office during the whole of the period from
29 February 2024 to 28 February 2025

Stephanie Reynolds
Michael Corbally
Rema Bailey

The director shown below has held office during the period of
21 June 2024 to 28 February 2025

Roland Polyak

The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
11 November 2025

And signed on behalf of the board by:
Name: Rema Bailey
Status: Director

# AREMATHERAPY C.I.C.

## Profit And Loss Account

for the Period Ended 28 February 2025

| 2025 | 11 months to 28 February 2024
--- | --- | ---
| £ | £
Turnover: | 10,768 | 262
Cost of sales: | ( 1,444 ) | 0
Gross profit(or loss): | 9,324 | 262
Administrative expenses: | ( 9,210 ) | ( 262 )
Operating profit(or loss): | 114 | 0
Profit(or loss) before tax: | 114 | 0
Profit(or loss) for the financial year: | 114 | 0

# AREMATHERAPY C.I.C.

## Balance sheet

As at 28 February 2025

| Notes | 2025 | 11 months to 28 February 2024
--- | --- | --- | ---
|  | £ | £
Fixed assets
Tangible assets: | 3 | 553 | 0
Total fixed assets: |  | 553 | 0
Current assets
Cash at bank and in hand: |  | 91 | 10,000
Total current assets: |  | 91 | 10,000
Net current assets (liabilities): |  | 91 | 10,000
Total assets less current liabilities: |  | 644 | 10,000
Creditors: amounts falling due after more than one year: | 4 | ( 262 ) |
Accruals and deferred income: |  | ( 268 ) | ( 10,000 )
Total net assets (liabilities): |  | 114 | 0
Members' funds
Profit and loss account: |  | 114 | 0
Total members' funds: |  | 114 | 0

The notes form part of these financial statements

# AREMATHERAPY C.I.C.

## Balance sheet statements

For the year ending 28 February 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 11 November 2025
and signed on behalf of the board by:

Name: Rema Bailey
Status: Director

The notes form part of these financial statements

# AREMATHERAPY C.I.C.

## Notes to the Financial Statements

for the Period Ended 28 February 2025

- ## 1. Accounting policies

  Basis of measurement and preparation

  These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

  Turnover policy

  Turnover represents net invoiced sales of goods and services, excluding value added tax

  Tangible fixed assets depreciation policy

  Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life Computer Equipment is depreciated at 20% on the Reducing Balance Method

  Intangible fixed assets amortisation policy

  Amortization is provided on all intangible assets at 20% straight Line method

# AREMATHERAPY C.I.C.

## Notes to the Financial Statements

for the Period Ended 28 February 2025

- ## 2. Employees

  | 2025 | 11 months to 28 February 2024
  --- | --- | ---
  Average number of employees during the period | 0 | 0

# AREMATHERAPY C.I.C.

## Notes to the Financial Statements

for the Period Ended 28 February 2025

## 3. Tangible assets

| Land & buildings | Plant & machinery | Fixtures & fittings | Office equipment | Motor vehicles | Total
--- | --- | --- | --- | --- | --- | ---
Cost | £ | £ | £ | £ | £ | £
At 29 February 2024 |  |  |  | 0 |  | 0
Additions |  |  |  | 691 |  | 691
Disposals |  |  |  |  |  |
Revaluations |  |  |  |  |  |
Transfers |  |  |  |  |  |
At 28 February 2025 |  |  |  | 691 |  | 691
Depreciation |  |  |  |  |  |
At 29 February 2024 |  |  |  | 0 |  | 0
Charge for year |  |  |  | 138 |  | 138
On disposals |  |  |  |  |  |
Other adjustments |  |  |  |  |  |
At 28 February 2025 |  |  |  | 138 |  | 138
Net book value |  |  |  |  |  |
At 28 February 2025 |  |  |  | 553 |  | 553
At 28 February 2024 |  |  |  | 0 |  | 0

# AREMATHERAPY C.I.C.

## Notes to the Financial Statements

for the Period Ended 28 February 2025

## 4. Creditors: amounts falling due after more than one year note

| 2025
--- | ---
| £
Other creditors | 262 |
Total | 262

# COMMUNITY INTEREST ANNUAL REPORT

### AREMATHERAPY C.I.C.

### Company Number: 14740780 (England and Wales)

### Year Ending: 28 February 2025

Company activities and impact

I'm delighted to say that Arematherapy CIC succeeded in running two main transformative programmes during this particular year with two different groups, namely, domestic abuse survivors and disadvantaged youths and their family members. Our participants had the opportunity to embark on a journey of self-discovery, creative expression, and personal growth, using tools like poetry, music, and clay art to explore their identities and resilience. Each of our programmes commenced by setting a foundation of trust and mindfulness. Participants engaged in breathing exercises, introduced themselves through an icebreaker activity, and collectively established group guidelines to create a safe, supportive space. Participants were able to explore themes of identity and resilience through poetry and spoken word, found their voice through music, and began shaping their personal narratives in clay. This group activity brought out unique stories, reflecting the diverse experiences of each participant. Our participants also wrote personal poetry and lyrics, collaborated on songwriting, and deepened their clay sculpting techniques. The sharing of creative works fostered a strong sense of community and connection among the group. Each programme culminated in an important celebration of growth and resilience. Participants reflected on their progress, practiced gratitude, and showcased their creative works. This allowed each person to set intentions for the future, with an emphasis on the continuation of healing through their new found creativity.

Consultation with stakeholders

No consultation with stakeholders

Directors' remuneration

The total amount paid or receivable by directors in respect of qualifying services was £4,253 There were no other transactions or arrangements in connection with the remuneration of directors, or compensation for director’s loss of office, which require to be disclosed.

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
11 November 2025

And signed on behalf of the board by:
Name: Rema Bailey
Status: Director